Tom Dumoulin says Wiggins' TUE case stinks

Tom Dumoulin of Giant-Alpecin has criticised Bradley Wiggins’ decision to seek a Therapeutic Use Exemption (TUE) to take the powerful corticoid triamcinolone before targeting the most important Grand Tours in his career.